These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 23122746)

  • 1. Comments to "The astonishing hypothesis" by Niels de Fine Olivarius (NdFO).
    Lauritzen T; Borch-Johnsen K
    Prim Care Diabetes; 2013 Apr; 7(1):69. PubMed ID: 23122746
    [No Abstract]   [Full Text] [Related]  

  • 2. Glycated haemoglobin does not accurately predict average capillary glucose in non insulin-treated type 2 diabetes: The PRISMA study experience.
    Trevisan R; Bonizzoni E; Bosi E; Ceriello A; Cucinotta D; Giorgino F; Tiengo A; Scavini M
    Nutr Metab Cardiovasc Dis; 2016 Feb; 26(2):169-70. PubMed ID: 26803592
    [No Abstract]   [Full Text] [Related]  

  • 3. Is glycemic control a quinidine-like intervention?
    Bloomgarden ZT
    J Diabetes; 2014 Sep; 6(5):387-8. PubMed ID: 24842383
    [No Abstract]   [Full Text] [Related]  

  • 4. Diabetes: glycated hemoglobin is a marker of diabetes and CVD risk.
    Wareham NJ; Pfister R
    Nat Rev Cardiol; 2010 Jul; 7(7):367-8. PubMed ID: 20577298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decrease mortality in type II diabetes mellitus: glycemic and renal function control.
    Borghi C; Ventura F
    J Cardiovasc Med (Hagerstown); 2018 Feb; 19 Suppl 1():e13-e15. PubMed ID: 29538138
    [No Abstract]   [Full Text] [Related]  

  • 6. ADAG study group data links A1C levels with empirically measured blood glucose values - new treatment guidelines will now be needed.
    Klonoff DC
    J Diabetes Sci Technol; 2014 May; 8(3):439-43. PubMed ID: 24876603
    [No Abstract]   [Full Text] [Related]  

  • 7. Is there a U-shaped curve of A1c versus mortality?
    Bloomgarden ZT; Drexler A
    J Diabetes; 2012 Jun; 4(2):107-8. PubMed ID: 22443259
    [No Abstract]   [Full Text] [Related]  

  • 8. Back to glycemic control: An alternative look at the results of cardiovascular outcome trials in type 2 diabetes.
    Mannucci E; Monami M; Ceriello A; Rotella CM
    Nutr Metab Cardiovasc Dis; 2017 Apr; 27(4):375-377. PubMed ID: 28242233
    [No Abstract]   [Full Text] [Related]  

  • 9. An interview with the authors of "Is there a U-shaped curve of A1c vs. mortality?".
    Bloomgarden Z; Drexler A
    J Diabetes; 2012 Jun; 4(2):109. PubMed ID: 22583822
    [No Abstract]   [Full Text] [Related]  

  • 10. Non-alcoholic fatty liver disease and type 2 diabetes: Importance of glycemic control.
    Bloomgarden Z
    J Diabetes; 2017 Aug; 9(8):722-723. PubMed ID: 28513098
    [No Abstract]   [Full Text] [Related]  

  • 11. [Diabetes mellitus--diagnosis and blood glucose control].
    Elke B; Käser L; Berneis K; Spinas G; Battegay E
    Praxis (Bern 1994); 2008 May; 97(10):529-37; quiz 538-9. PubMed ID: 18595368
    [No Abstract]   [Full Text] [Related]  

  • 12. Glycemic Targets in Diabetes Care: Emerging Clarity after Accord.
    Buse JB
    Trans Am Clin Climatol Assoc; 2015; 126():62-76. PubMed ID: 26330660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The shifting paradigm in the treatment of type 2 diabetes mellitus-A cardiologist's perspective.
    Fatima S; Jameel A; Ayesha F; Menzies DJ
    Clin Cardiol; 2017 Nov; 40(11):970-973. PubMed ID: 28841228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and Mode of Action of Diabetes Medications in comparison with 5-Aminolevulinic Acid (5-ALA).
    Rehani PR; Iftikhar H; Nakajima M; Tanaka T; Jabbar Z; Rehani RN
    J Diabetes Res; 2019; 2019():4267357. PubMed ID: 31781665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HbA1c variability predicts cardiovascular complications in type 2 diabetes regardless of being at glycemic target.
    Ceriello A; Lucisano G; Prattichizzo F; La Grotta R; Franzén S; Svensson AM; Eliasson B; Nicolucci A
    Cardiovasc Diabetol; 2022 Jan; 21(1):13. PubMed ID: 35073913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Simplified Approach Using Rate of Change Arrows to Adjust Insulin With Real-Time Continuous Glucose Monitoring.
    Klonoff DC; Kerr D
    J Diabetes Sci Technol; 2017 Nov; 11(6):1063-1069. PubMed ID: 28884599
    [No Abstract]   [Full Text] [Related]  

  • 17. Cardiovascular benefit in the limelight: shifting type 2 diabetes treatment paradigm towards early combination therapy in patients with overt cardiovascular disease.
    Shehadeh N; Raz I; Nakhleh A
    Cardiovasc Diabetol; 2018 Aug; 17(1):117. PubMed ID: 30134893
    [No Abstract]   [Full Text] [Related]  

  • 18. Empagliflozin/metformin (Synjardy) for type 2 diabetes.
    Med Lett Drugs Ther; 2015 Dec; 57(1484):172-4. PubMed ID: 26670554
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical markers associated with glycaemic response to dipeptidyl peptidase-4 inhibitor therapy.
    Yamagishi SI
    Diabetes Metab Res Rev; 2018 Oct; 34(7):e3024. PubMed ID: 29763999
    [No Abstract]   [Full Text] [Related]  

  • 20. Diabetes. Insights from the extended follow-up of the ACCORD trial.
    Zoungas S; Woodward M
    Nat Rev Cardiol; 2011 Jun; 8(6):308-10. PubMed ID: 21502962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.